Logo image of LHYFE.PA

LHYFE SAS (LHYFE.PA) Stock Fundamental Analysis

EPA:LHYFE - Euronext Paris - Matif - FR0014009YQ1 - Common Stock - Currency: EUR

3.365  -0.1 (-3.03%)

Fundamental Rating

2

Taking everything into account, LHYFE scores 2 out of 10 in our fundamental rating. LHYFE was compared to 62 industry peers in the Oil, Gas & Consumable Fuels industry. LHYFE may be in some trouble as it scores bad on both profitability and health. LHYFE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LHYFE had negative earnings in the past year.
In the past year LHYFE has reported a negative cash flow from operations.
LHYFE had negative earnings in each of the past 5 years.
LHYFE had a negative operating cash flow in each of the past 5 years.
LHYFE.PA Yearly Net Income VS EBIT VS OCF VS FCFLHYFE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -20M -40M -60M

1.2 Ratios

With a Return On Assets value of -15.40%, LHYFE is not doing good in the industry: 92.06% of the companies in the same industry are doing better.
The Return On Equity of LHYFE (-36.47%) is worse than 90.48% of its industry peers.
Industry RankSector Rank
ROA -15.4%
ROE -36.47%
ROIC N/A
ROA(3y)-15.2%
ROA(5y)-13.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LHYFE.PA Yearly ROA, ROE, ROICLHYFE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 50 -50 100

1.3 Margins

The Gross Margin of LHYFE (68.56%) is better than 74.60% of its industry peers.
LHYFE's Gross Margin has declined in the last couple of years.
LHYFE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.09%
GM growth 5YN/A
LHYFE.PA Yearly Profit, Operating, Gross MarginsLHYFE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -10K -20K -30K -40K -50K

More info and screens

3

2. Health

2.1 Basic Checks

LHYFE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LHYFE remains at a similar level compared to 1 year ago.
LHYFE has a worse debt/assets ratio than last year.
LHYFE.PA Yearly Shares OutstandingLHYFE.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 10M 20M 30M 40M
LHYFE.PA Yearly Total Debt VS Total AssetsLHYFE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

LHYFE has an Altman-Z score of 0.05. This is a bad value and indicates that LHYFE is not financially healthy and even has some risk of bankruptcy.
LHYFE has a worse Altman-Z score (0.05) than 77.78% of its industry peers.
LHYFE has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
LHYFE has a Debt to Equity ratio (0.38) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 0.05
ROIC/WACCN/A
WACC7.19%
LHYFE.PA Yearly LT Debt VS Equity VS FCFLHYFE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 50M -50M 100M

2.3 Liquidity

LHYFE has a Current Ratio of 1.69. This is a normal value and indicates that LHYFE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.69, LHYFE is in the better half of the industry, outperforming 65.08% of the companies in the same industry.
LHYFE has a Quick Ratio of 1.68. This is a normal value and indicates that LHYFE is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of LHYFE (1.68) is better than 73.02% of its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.68
LHYFE.PA Yearly Current Assets VS Current LiabilitesLHYFE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for LHYFE have decreased strongly by -13.67% in the last year.
LHYFE shows a strong growth in Revenue. In the last year, the Revenue has grown by 282.65%.
LHYFE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 660.01% yearly.
EPS 1Y (TTM)-13.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.08%
Revenue 1Y (TTM)282.65%
Revenue growth 3Y660.01%
Revenue growth 5YN/A
Sales Q2Q%332.04%

3.2 Future

Based on estimates for the next years, LHYFE will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.36% on average per year.
Based on estimates for the next years, LHYFE will show a very strong growth in Revenue. The Revenue will grow by 201.94% on average per year.
EPS Next Y1.54%
EPS Next 2Y3.03%
EPS Next 3Y18.36%
EPS Next 5YN/A
Revenue Next Year403.98%
Revenue Next 2Y441.11%
Revenue Next 3Y357.88%
Revenue Next 5Y201.94%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LHYFE.PA Yearly Revenue VS EstimatesLHYFE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
LHYFE.PA Yearly EPS VS EstimatesLHYFE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 -0.2 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LHYFE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LHYFE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LHYFE.PA Price Earnings VS Forward Price EarningsLHYFE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LHYFE.PA Per share dataLHYFE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

LHYFE's earnings are expected to grow with 18.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.03%
EPS Next 3Y18.36%

More info and screens

0

5. Dividend

5.1 Amount

LHYFE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LHYFE SAS

EPA:LHYFE (3/7/2025, 7:00:00 PM)

3.365

-0.1 (-3.03%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)03-27 2025-03-27/amc
Inst Owners9.78%
Inst Owner ChangeN/A
Ins Owners21.94%
Ins Owner ChangeN/A
Market Cap161.42M
Analysts83.08
Price Target5.32 (58.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.12%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.26%
EPS NY rev (3m)3.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 62.04
P/FCF N/A
P/OCF N/A
P/B 1.87
P/tB 2.24
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)-0.75
Fwd EYN/A
FCF(TTM)-1.61
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS0.05
BVpS1.8
TBVpS1.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.4%
ROE -36.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.56%
FCFM N/A
ROA(3y)-15.2%
ROA(5y)-13.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.09%
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1060.09%
Cap/Sales 1994.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.68
Altman-Z 0.05
F-Score4
WACC7.19%
ROIC/WACCN/A
Cap/Depr(3y)1295.36%
Cap/Depr(5y)5593.21%
Cap/Sales(3y)2496.07%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.08%
EPS Next Y1.54%
EPS Next 2Y3.03%
EPS Next 3Y18.36%
EPS Next 5YN/A
Revenue 1Y (TTM)282.65%
Revenue growth 3Y660.01%
Revenue growth 5YN/A
Sales Q2Q%332.04%
Revenue Next Year403.98%
Revenue Next 2Y441.11%
Revenue Next 3Y357.88%
Revenue Next 5Y201.94%
EBIT growth 1Y-13.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year19.95%
EBIT Next 3Y28.45%
EBIT Next 5Y22.16%
FCF growth 1Y-398.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-156.18%
OCF growth 3YN/A
OCF growth 5YN/A